Zoledronic acid-induced orbital inflammation: A case report
Indian Journal of Physiology and Pharmacology · 09.07.2026 · 1-4
DOI: 10.25259/ijpp_542_2025 ↗Kurz gefasst
Fallbericht in der Zeitschrift Indian Journal of Physiology and Pharmacology, online erschienen am 09.07.2026. Verfasst von Saramol Binu und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Zoledronic acid (ZA), a bisphosphonate (BP), is a synthetic analogue of the intrinsic bone mineralisation regulator widely used in various bone disorders. Orbital inflammation is a rare adverse effect of ZA. Among reported adverse events, approximately 2% (3474) of cases involve ocular disorders, with only about 130 cases of eye inflammation documented worldwide. We report the case of a 59-year-old male patient diagnosed with multiple myeloma who had an acute onset of orbital inflammation within 24 h of ZA infusion. The patient was managed with intravenous and topical steroids and eye drops. In general, BPs are safe and well-tolerated; however, early identification and patient education about potential side effects can help minimise risks and improve outcomes.
Zitieren
APA
Binu, S., Abraham, R. A., P.R, P., & S, H. (2026). Zoledronic acid-induced orbital inflammation: A case report. Indian Journal of Physiology and Pharmacology, 0, 1-4. https://doi.org/10.25259/ijpp_542_2025
Vancouver
Binu S, Abraham RA, P.R P, S H. Zoledronic acid-induced orbital inflammation: A case report. Indian Journal of Physiology and Pharmacology. 2026;0:1-4. doi:10.25259/ijpp_542_2025
BibTeX
@article{Binu2026,
author = {Binu, Saramol and Abraham, Royce An and P.R, Parvathy and S, Harikrishnan},
title = {Zoledronic acid-induced orbital inflammation: A case report},
journal = {Indian Journal of Physiology and Pharmacology},
year = {2026},
volume = {0},
pages = {1--4},
doi = {10.25259/ijpp_542_2025}
}
EUVIMED